These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38982480)

  • 21. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
    Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
    Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
    Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
    Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paired like homeodomain 1 and SAM and SH3 domain-containing 1 in the progression and prognosis of head and neck squamous cell carcinoma.
    Jin Y; Qin X
    Int J Biochem Cell Biol; 2020 Oct; 127():105846. PubMed ID: 32905855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
    Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S
    Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma.
    Georgy SR; Cangkrama M; Srivastava S; Partridge D; Auden A; Dworkin S; McLean CA; Jane SM; Darido C
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26063791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.
    Lang L; Shay C; Zhao X; Xiong Y; Wang X; Teng Y
    J Hematol Oncol; 2019 Dec; 12(1):132. PubMed ID: 31805962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KAT7 enhances the proliferation and metastasis of head and neck squamous carcinoma by promoting the acetylation level of LDHA.
    Lu Y; Wang Y; Zhang L; Ma Z; Yu K; Shu Y; Zou X; Yang J; Liu X; Wang C; Du Y; Li Q
    Cancer Lett; 2024 May; 590():216869. PubMed ID: 38593918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.
    Wu YL; Liu W; Zhao T; Jin J
    Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
    Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
    J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma.
    Liu J; Wang Y; Chen X; Chen X; Zhang M
    Diagn Pathol; 2024 Oct; 19(1):134. PubMed ID: 39375732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased FGL1 Expression Predicts Poor Prognosis and Promotes EMT in Head and Neck Squamous Cell Carcinoma.
    Pan Z; Hu W; Huang J; Zheng Z; Lin E; Wang P; Mao L
    Biochem Genet; 2024 Jun; 62(3):2066-2081. PubMed ID: 37843652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
    Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S
    Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models.
    Lee TW; Singleton DC; Harms JK; Lu M; McManaway SP; Lai A; Tercel M; Pruijn FB; Macann AMJ; Hunter FW; Wilson WR; Jamieson SMF
    Mol Oncol; 2024 Aug; 18(8):1885-1903. PubMed ID: 38426642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
    Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
    Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
    Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
    J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
    Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.
    Wang H; Nan S; Wang Y; Xu C
    J Cell Mol Med; 2021 May; 25(10):4596-4607. PubMed ID: 33733587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.